A phase II study of gemcitabine/nab-paclitaxel/S-1 combination neoadjuvant chemotherapy for patients with borderline resectable pancreatic cancer with arterial contact
Naru Kondo, Kenichiro Uemura, Takeshi Sudo, Yasushi Hashimoto, Tatsuaki Sumiyoshi, Kenjiro Okada, Shingo Seo, Hiroyuki Otsuka, Yoshiaki Murakami, Shinya Takahashi
Topics & Concepts
GemcitabineMedicineRegimenNeoadjuvant therapyPancreatic cancerChemotherapyInternal medicinePhases of clinical researchOncologyPaclitaxelSurgeryCancerBreast cancerPancreatic and Hepatic Oncology ResearchPancreatitis Pathology and TreatmentLymphatic System and Diseases